Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation

被引：25

作者：

Mitsuhata, N

Fujita, R

Ito, S

Mannami, M

Keimei, K

机构：

[1] Kure Kyosai Hosp, Dept Urol, Hiroshima, Japan

[2] Uwajima Tokushukai Hosp, Dept Urol, Uwajima, Japan

来源：

TRANSPLANTATION | 2005年 / 80卷 / 09期

关键词：

D O I：

10.1097/01.tp.0000184275.81396.45

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1355 / 1355

页数：1

共 8 条

[1] Rituximab as treatment for refractory kidney transplant rejection [J].

Becker, YT ;

Becker, BN ;

Pirsch, JD ;

Sollinger, HW .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :996-1001

[2]

CAIWHANTANATORN K, 2003, BRIT J HAEMATOL, V121, P913

[3] Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma [J].

Lemieux, B ;

Tartas, S ;

Traulle, C ;

Espinouse, D ;

Thieblemont, C ;

Bouafia, F ;

Alhusein, Q ;

Antal, D ;

Salles, G ;

Coiffier, B .

BONE MARROW TRANSPLANTATION, 2004, 33 (09) :921-923

[4]

MALONEY DG, 1994, BLOOD, V84, P2457

[5] The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation [J].

Pescovitz, MD .

PEDIATRIC TRANSPLANTATION, 2004, 8 (01) :9-21

[6] Successful Al-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis [J].

Sawada, T ;

Fuchinoue, S ;

Teraoka, S .

TRANSPLANTATION, 2002, 74 (09) :1207-1210

[7] Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics [J].

Vieira, CA ;

Agarwal, A ;

Book, BK ;

Sidner, RA ;

Bearden, CM ;

Gebel, HM ;

Roggero, AL ;

Fineberg, NS ;

Taber, T ;

Kraus, MA ;

Pescovitz, MD .

TRANSPLANTATION, 2004, 77 (04) :542-548

[8]

Voog E, 2003, NEW ENGL J MED, V348, P2691

← 1 →